A pilot trial of anti-KIR antibody with or without 5-azacitidine for myelodysplastic syndrome.

被引：0
|
作者：
Yalniz, Fevzi Firat
Daver, Naval Guastad
Kornblau, Steven Mitchell
Ohanian, Maro
Borthakur, Gautam
Dinardo, Courtney Denton
Konopleva, Marina
Burger, Jan Andreas
Gasior, Yvonne
Pierce, Sherry
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.7067
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7067
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Pilot Trial of Lirilumab With or Without Azacitidine for Patients With Myelodysplastic Syndrome
    Yalniz, Fevzi Firat
    Daver, Naval
    Rezvani, Katayoun
    Kornblau, Steven
    Ohanian, Maro
    Borthakur, Gautam
    DiNardo, Courtney D.
    Konopleva, Marina
    Burger, Jan
    Gasior, Yvonne
    Pierce, Sherry
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (10): : 658 - +
  • [2] Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
    Nishihori, Taiga
    Perkins, Janelle
    Mishra, Asmita
    Komrokji, Rami
    Kim, Jongphil
    Kharfan-Dabaja, Mohamed A.
    Perez, Lia
    Lancet, Jeffrey
    Fernandez, Hugo
    List, Alan
    Anasetti, Claudio
    Field, Teresa
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 776 - 780
  • [3] EXPERIENCE WITH 5-AZACITIDINE (AZA) IN MYELOPROLIFERATIVE MYELODYSPLASTIC SYNDROME (SMD/MP)
    Javier Gonzalez, K. P.
    Ortiz, S.
    Villegas, C.
    Orero, M. T.
    Collado, R.
    Roig, M.
    Perez, P.
    Luna, I
    Ivars, D.
    Linares, M.
    Lopez, M.
    HAEMATOLOGICA, 2015, 100 : 257 - 257
  • [4] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
    Nam, Seung-Hyun
    Lim, Taekyu
    Kim, Bong-Seog
    BLOOD, 2012, 120 (21)
  • [5] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
    Nam, S.
    Lim, T.
    Kim, B.
    HAEMATOLOGICA, 2013, 98 : 588 - 588
  • [6] Autoimmune hemolytic anemia in a patient with myelodysplastic syndrome: Responding to 5-azacitidine therapy
    Kaur, Jaspreet
    Tuler, Shahaf
    Dasanu, Constantin A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (07) : 1775 - 1778
  • [7] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Huong Thi Thanh Tran
    Kim, Hee Nam
    Lee, Il-Kwon
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
  • [8] DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Tran, Huong Thi Thanh
    Kim, Hee Nam
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Lee, Il-Kwon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Hoon, Kook
    Hwang, Tai Ju
    Kim, Hyeoung-Joon
    BLOOD, 2009, 114 (22) : 1091 - 1092
  • [9] Late Hematological Improvement of Myelodysplastic Syndrome Following Treatment with 5-Azacitidine Therapy
    Takaoka, Kensuke
    Hangaishi, Akira
    Ito, Ayumu
    Morioka, Takehiko
    Kida, Michiko
    Usuki, Kensuke
    INTERNAL MEDICINE, 2014, 53 (19) : 2241 - 2243
  • [10] EXPERIENCE WITH THE USE OF 5-AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW/INTERMEDIATE RISK
    Llorente Dunia, De Miguel
    Lopez Nuria, Golbano
    Morfa Miguel, Diaz
    Juanis Jaime, Arbeteta
    Sanz Dolores, Morales
    Perez Dolores, Subira
    Maqueda Cristina, Fernandez
    Ramo Alejandro, Vazquez
    Martin Sonia, Herrero
    Albiz Blanca, Pinedo
    HAEMATOLOGICA, 2016, 101 : 152 - 152
12345